BIOMAT Database Logo BIOMAT Database Logo

LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells. 2018

Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital, Jena, Germany.

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D000074084 THP-1 Cells A human leukemia monocytic cell line derived from a patient with LEUKEMIA, MONOCYTIC, ACUTE. It is used as a model to study the function of MONOCYTES and MACROPHAGES, their signaling pathways, nutrient and drug transport. THP-1 Cell Line,Cell Line, THP-1,Cell Lines, THP-1,Cell, THP-1,Cells, THP-1,THP 1 Cell Line,THP 1 Cells,THP-1 Cell,THP-1 Cell Lines
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D056466 Histone Demethylases Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism. Histone Demethylase,Histone Lysine Demethylase,Histone Arginine Demethylases,Histone Lysine Demethylases,Arginine Demethylases, Histone,Demethylase, Histone,Demethylase, Histone Lysine,Demethylases, Histone,Demethylases, Histone Arginine,Demethylases, Histone Lysine,Lysine Demethylase, Histone,Lysine Demethylases, Histone
D023041 Xenograft Model Antitumor Assays In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness. Tumor Xenograft Assay,Xenograft Antitumor Assays,Antitumor Assays, Xenograft Model,Antitumor Assay, Xenograft,Antitumor Assays, Xenograft,Assay, Tumor Xenograft,Assay, Xenograft Antitumor,Assays, Tumor Xenograft,Assays, Xenograft Antitumor,Tumor Xenograft Assays,Xenograft Antitumor Assay,Xenograft Assay, Tumor,Xenograft Assays, Tumor

Related Publications

Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling.
July 2021, Acta biochimica et biophysica Sinica,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Capsaicin: A "hot" KDM1A/LSD1 inhibitor from peppers.
October 2020, Bioorganic chemistry,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.
March 2022, Investigative ophthalmology & visual science,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Repression of LSD1/KDM1A activity improves the response of liver cancer cells to the lenvatinib.
March 2024, Discover. Oncology,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
November 2014, Leukemia,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
July 2017, Leukemia,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Inhibition of LSD1 via SP2509 attenuated the progression of rheumatoid arthritis.
May 2024, Immunologic research,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A.
July 2019, Nutrients,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Therapeutic potential of targeting LSD1/ KDM1A in cancers.
January 2022, Pharmacological research,
Jürgen Sonnemann, and Miriam Zimmermann, and Christian Marx, and Franziska Ebert, and Sabine Becker, and Marie-Luise Lauterjung, and James F Beck
Annual review of LSD1/KDM1A inhibitors in 2020.
March 2021, European journal of medicinal chemistry,
Copied contents to your clipboard!